The goal is to inform users on how to best utilize AI tools while also practicing caution, as many are still in their early stages of deployment and can pose risks. 

A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

A total of 80 healthcare companies are among those that brought in the most revenue for the fiscal year, according to the magazine's most recent rankings.

The retail giant recently announced plans to invest in its pharmacists and opticians. 

Healthcare companies, including manufacturers that produce health products, announced a total of 33,085 layoffs in the first five months of 2023—an 81% increase compared to the same time frame in 2022.

Bullying and other inappropriate workplace behaviors have been linked to an increased risk of errors and worse patient outcomes. 

The FDA’s process of reviewing and approving drugs and devices could be put on hold, if lawmakers fail to reach a deal related to the debt ceiling.

Commercial health insurers tend to reimburse providers considerably more per service than their governmental counterparts. However, they’re also much more likely to initially deny claims.